COMMUNIQUÉS West-GlobeNewswire

HUTCHMED Announces Appointment of Acting Chief Executive Officer
25/08/2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J, Aug. 25, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that Dr Weiguo Su, an Executive Director of the Company [...]
La marque suisse légendaire BILATTE inaugure l’ère 3.0 des soins esthétiques médicaux à domicile
24/08/2025
MONTREUX, Suisse, 24 août 2025 (GLOBE NEWSWIRE) -- BILATTE, marque légendaire de recherche médicale et de rétablissement originaire de Montreux, en Suisse, connue comme la « Mecque mondiale de l’anti-âge », annonce ce [...]
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
24/08/2025
RIYADH, Saudi Arabia, Aug. 24, 2025 (GLOBE NEWSWIRE) -- In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has [...]
Celularity Receives Nasdaq Notice Regarding Form 10-Q
22/08/2025
FLORHAM PARK, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company focused on addressing age-related and degenerative [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
22/08/2025
SAN CARLOS, Calif., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor
22/08/2025
Aptose also Receives Additional Advance from Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML SAN DIEGO and TORONTO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“ [...]
MEDIROM launches cryptocurrency strategy with next-generation proof of human technology, "World"
22/08/2025
Acquires ETH as part of financial strategy TOKYO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM) (the “Company”, “we” or “us”), [...]
Tevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma
22/08/2025
WARREN, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN ), announced today that it has been named in BINJE’s BEST Health Care 2025: Companies, Organizations [...]

Pages